UNC study finds genetic marker in vitamin D receptor gene associated with increased pancreatic cancer survival
- Posted: June 21, 2012
Pancreatic cancer patients with a genetic marker linked to increased expression of the receptor for vitamin D have higher rates of overall survival, according to findings presented at the American Association for Cancer Research's Pancreatic Cancer: Progress and Challenges conference, held in Lake Tahoe, Nev., June 18-21. The study was conducted by scientists from the University of North Carolina at Chapel Hill Eshelman School of Pharmacy. UNC is home to the Lineberger Comprehensive Cancer Center.
Among the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.